1 / 44

Modern Management of Respiratory Infections

Modern Management of Respiratory Infections. Ralph Gonzales, MD, MSPH Associate Professor of Medicine; Epidemiology & Biostatistics University of California, San Francisco August 16, 2006. General Approach. Making the Diagnosis Excluding Serious Illness Do I need a Diagnostic Test?

elton-bowman
Télécharger la présentation

Modern Management of Respiratory Infections

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Modern Management of Respiratory Infections Ralph Gonzales, MD, MSPH Associate Professor of Medicine; Epidemiology & Biostatistics University of California, San Francisco August 16, 2006

  2. General Approach • Making the Diagnosis • Excluding Serious Illness • Do I need a Diagnostic Test? • Determining Treatment • Symptomatic Therapy • Antimicrobial Therapy • Communicating Prognosis • When to Return for Evaluation

  3. Management Principles for Uncomplicated Acute Bronchitis

  4. Bronchitis-CDC; ACP; AAFP; IDSA… 2001 • “The evaluation of adults with acute cough illness… should focus on ruling out serious illness, particularly pneumonia” • In healthy, nonelderly adults, pneumonia is uncommon in the absence of vital sign abnormalities or asymmetrical lung sounds, and CXR is usually not indicated. • When cough>3 weeks, CXR may be warranted in absence of other known causes. Gonzales et al, 2001

  5. Acute Cough Illness-Ruling Out Pneumonia Likelihood Ratio Ranges LR +LR - Fever 1.7-2.1 0.6-0.7 Chills 1.3-1.7 0.7-0.9 Tachypnea 1.5-3.4 0.8 Tachycardia 1.6-2.3 0.5-0.7 Hyperthermia 1.4-4.4 0.6-0.8 Dullness to Percussion 2.2-4.3 0.8-0.9 Crackles 1.6-2.7 0.6-0.9 Rhonchi 1.4-1.5 0.8-0.9 Egophany 2.0-8.6 0.8-1.0 Leukocytosis 1.9-3.7 0.3-0.6 Metlay et al,

  6. Pneumonia Post Test Probabilities PreTest Prob Metlay et al.

  7. When to consider zebras… • Cough > 3 weeks and normal CXR • Meds, asthma, GERD, postnasal drip, pertussis • Nocturnal Cough • GERD/postnasal drip, cough-variant asthma, CHF

  8. Pertussis…not just for children anymore • DPT-related immunity wanes as early as 3 years… and absent after 10-12 years • attack rates as high as 100% • 10-15% adults seeking care for persistent cough have evidence of pertussis • No clinical features distinguish pertussis in previously immunized adults

  9. Pertussis • Diagnosis • Dacron nasopharyngeal swab or wash • PCR is now standard… much better sensitivity than culture or DFA • Coordinate with public health dept • Treatment • Erythromycin, azithromycin or clarithromycin • Probably won’t help cough duration, which can last 3-6 months • Reasonable to provide empirical Abx treatment to contacts with cough, and close contacts/household members as prophylaxis.

  10. Pertussis Boosters for Adolescents • Adolescents and adults believed to be vectors of increasing pertussis incidence in young children. • DTaP and Tdap: FDA approval 2005 • Boostrix (GSK; age 10-18 yrs) • Adacel (Sanofi Pasteur; age 11-64 yrs) • ACIP/NIP Recommendations: 2006 • Single DTaP/Tdap instead of dT at age 11-18

  11. Cough-Variant Asthma • Cough > 2-3 weeks • Lack of wheezing • Normal PFTs • Features • Worse at night • Worse with exercise/cold • Diagnosis • Improved symptoms with bronchodilator • Positive methacholine challenge test

  12. Acute Bronchitis-Therapeutic Objectives SymptomsPathophysiology Treatment • Cough -bronchial RAD -bronchodilators -mucus production -decongestants -post-nasal drip -sinus therapy -acid reflux -H2B; PPI -cough suppressants • Wheezing/SOB -bronchial RAD -bronchodilators

  13. Resolution of Acute Bronchitis Stott, BMJ 1976

  14. Uncomplicated Acute Bronchitis-azithromycin vs. vitamin C (Lancet 2002;359;1648-54) Return to Usual Activities

  15. Acute Bronchitis:-bronchial hyperresponsiveness Eur Resp J 1994;7:1239

  16. Acute cough illness treatment-bronchodilator treatment Randomized, placebo controlled trials Melbye bronchitis 73 fenoterol aerosol Decrease symptoms 1991 Improved FEV1 Hueston bronchitis 34 oral albuterol vs. Decrease cough @ 1 week 1991 erythromycin (41% vs. 82%) Hueston bronchitis 46 albuterol aerosol vs. Decrease cough @ 1 week 1994 (placebo + erythro) (61% vs. 91%) Littenberg nonspecific 104 albuterol aerosol No benefit 1996 cough

  17. OTC Cough Therapies-Cochrane Review, 2004 • Antitussives • codeine: 2 trials; no differences • dextromethorphan: 2 of 3 trials show benefit • Expectorants (guaifenesin): 1 of 2 trials benefit • Mucolytics: 1 trial inconsistent benefit • Antihistamine-Decongestant Combinations • 1 of 2 trials show benefit • Dextro-salbutamol: reduced nocturnal cough only

  18. Acute cough illness: evaluation summary Acute Cough Illness with or w/o phlegm Patient Characteristics Elderly Immunosuppression COPD or CHF Vital Sign Abnormalities HR > 100 bpm RR > 24 br/min, or T > 38o C PEx Findings Consolidation, or Pleural Effusion No Yes Yes Is Influenza Likely? Yes No No Negative Consider CXR Treatment Options* Positive Treat Pneumonia

  19. Acute Exacerbations of COPDAnn Intern Med 2001;134:595-99 Assessing Severity of Exacerbation worsening dyspnea increased sputum purulence increased sputum volume “severe” = all 3 present “moderate” = 2 of 3 present “mild” = 1 finding + (recent URI; unexplained fever; increased cough/wheeze; or 20% increase in RR or HR from baseline)

  20. AECB: Treatment Recs (1)Ann Intern Med 2001;134:595-99 • All AECB • CXR utility high among hospitalized and ED patients with AECB; ? Role in outpatient setting. • Inhaled bronchodilator therapy • beta-2 agonist and anticholinergic equal in efficacy, but anticholinergic have fewer/benign side effects • Use 2nd bronchodilator class only after 1st is at max dose

  21. AECB: Treatment Recs (2)Ann Intern Med 2001;134:595-99 • Moderate-severe AECB • pulse steroids up to 2 weeks if not currently taking • oxygen, with caution, in hypoxemic patients • Severe AECB • initial narrow-spectrum antibiotics • no RCTs show superiority of broad-spectrum agents • UPDATED MARCH 31, 2005 • Not recommended for AECB: • mucolytic agents; chest physiotherapy; methylxanthine bronchodilators

  22. AECB-Therapeutic Objectives SymptomsPathophysiology Treatment • Cough -bronchial RAD -bronchodilators -mucus production -decongestants/sinus -bronchial; post-nasal drip -acid reflux -H2B; PPI -cough suppressants • Wheezing/SOB -bronchial RAD -bronchodilators -inflammation -oral steroids -? Bacterial infection -? antibiotics -BiPAP

  23. AECB-Who’s at greatest risk for relapse? • Miravitlles et al. • Ischemic heart disease • Degree of dyspnea • # office visits previous year

  24. Asthma Exacerbations and Telithromycin Johnston SL, NEJM 2006;354:1632-4. • N=278; age 18-55; 90% white; mod-severe exacerbation • 1/3 oral steroids Telith Placebo P-value Baseline asthma score 3.0 2.8 ∆ asthma score 1.3 1.0 0.004 ∆ peak exp flow 78 l/m 67 l/m 0.28 Nausea 5% 0% 0.01 Diarrhea 10% 4% 0.09 No difference according to Chlamydia or Mycoplasma infection status… The ERA of Clinical Trials Registry… must report all prespecified outcomes

  25. Rhinosinusitis: Diagnosis (1) “The clinical diagnosis of acute bacterial rhinosinusitis should be reserved for…” [B] (1) rhinosinusitis symptoms > 7 days + (2) purulent nasal secretions + (3) maxillary pain/tenderness in face/teeth

  26. Rhinosinusitis: Diagnosis (2) “…rarely some patients with acute bacterial rhinosinusitis present with dramatic symptoms of severe unilateral maxillary pain, swelling and fever”

  27. Bacterial Sinusitis? Tough Call (a) CT scan criteria of air-fluid level or complete opacification. (b) Xray criteria of mucosal thickening, air-fluid level or complete opacification.

  28. Rhinosinusitis: Rx Studies *Percent improved or cured

  29. Rhinosinusitis: Abx Rx • “Acute rhinosinusitis resolves without antibiotic treatment in most cases” [A] • Antibiotic treatment should be reserved for patients with moderately severe symptoms who meet criteria for clinical diagnosis of acute bacterial rhinosinusitis and for those with severe symptoms…regardless of duration of illness.

  30. Acute Sinusitis-Therapeutic Objectives Symptoms Pathophysiology Treatment • Pain -increased sinus pressure due - sinus drainage inflammation & obstruction -nasal saline wash -nasal decongestant -if >7-10 days of Sx -NSAIDs - bacterial infection risk -Antibiotics • Congestion -increased mucus production -oral decongestants -infection; recurrent; allergic -nasal steroids

  31. Pharyngitis: Diagnosis • “Clinically screen all adult patients with pharyngitis for the presence of 4 criteria:” • history of fever • tonsillar exudates • tender anterior cervical LAN • absence of cough • “Do not test or treat patients with none or only 1 of these criteria…”

  32. Spectrum Bias in GAS Test Sensitivity of RAT Pediatrics Adults Centor Score 0 47 61* 1 65 61* 2 82 76 3 90* 90 4 90* 97 *groups combined in study Peds Ref: Hall MC et al. Pediatrics 2004;114:182 Adult Ref: Dimatteo LA et al. Ann Emerg Med 2001;38:648

  33. Pharyngitis: Abx Rx • “Test patients with 2-4 criteria using a rapid antigen test, and limit Abx to patients with positive test results [D]”, OR • “Test patients with 2 or 3 criteria, and limit Abx to patients with positive test results or patients with 4 criteria” [D], OR • “Do not use any diagnostic tests, and limit Abx to patients with 3 or 4 criteria [B]”

  34. Streptococcal Pharyngitis-Therapeutic Objectives SymptomsPathophysiology Treatment • sore throat -inflammation -NSAIDs -infection -antibiotics

  35. Prednisone for Pharyngitis (Bacterial)-Kiderman A et al, Br J Gen Pract 2005;55:218. -18-65 years; primary care -2+ Centor criteria -50% Strep Cx + -Oral Prednisone 60 mg for 1 or 2 days

  36. Delayed Antibiotic Prescriptions • Systematic Review: approx 50% decrease in antibiotic treatment • Br J Gen Pract. 2003 Nov;53(496):871-7. • Delayed Antibiotic Treatment of Otitis media (AAP; AAFP)…. • Definition of AOM (ie. “definite AOM”): • recent, usually abrupt, onset of sx and signs, AND • presence of middle ear effusion, AND • distinct tympanic erythema or otalgia

  37. Management of AOMGuideline (AAP;AAFP 2004) Child Age 2 mo to 12 yrs with uncomplicated AOM Assess and Treat Pain AgeDefinite Diagnosis Uncertain Diagnosis < 6 mo Abx Abx 6 mo - 2 yr Abx Abx if severe illness (T>39 or severe otalgia; else observe >2 yr Abx if severe; else observe Observe AND *Caregiver informed/agrees/monitors/returns; System in place for communication Abx observe Amoxicillin 80-90 mg/kg/day; unless T>39 C. or severe otalgia or treatment failure, then amox/clavulanate Observe 48-72 hr with assurance and appropriate f/u

  38. How to help patients say “no” to antibiotics for viral ARIs • Illness labeling: use “chest cold”, not “bronchitis” • Validate illness severity; focus on symptom relief • Provide a contingency plan • Discuss downside of unnecessary antibiotic use • risk of carriage/spread of antibiotic-resistant bacteria • Patient-physician communication • Explain the illness • Spend “enough” time • Treat with respect

  39. Therapeutic Windows in ARI Treatments • Influenza 2 days • GAS pharyngitis 2 days • To prevent ARF 10 days • Pertussis 7-10 days

  40. CDC/ACP/AAFP/IDSA-Antibiotic Principles for ARIs • Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JH, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: Background, Specific Aims and Methods.Ann Intern Med 2001;134:479-86. • Cooper RJ, Hoffman JR, Bartlett JG, Besser RE, Gonzales R, Hickner JH, Sande MA. Principles of appropriate antibiotic use for acute pharyngitis in adults: background.Ann Intern Med 2001;134:509-17 • Hickner JH, Bartlett JG, Besser RE, Gonzales R, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background.Ann Intern Med 2001;134:498-505. • Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JH, Hoffman JR, Sande MA. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background.Ann Intern Med 2001;134:521-29.

  41. Bronchitis References • Stott NC, West RR. Randomised controlled trial of antibiotics in patients with cough and purulent sputum. BMJ. 1976;2(6035):556-9. • Melbye H, Kongerud J, Vorland L. Reversible airflow limitation in adults with respiratory infection. Eur Respir J. 1994;7:1239-45. • Gonzales R, Steiner JF, Lum A et al. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults.JAMA. 1999;281:1512-9. • Evans AT, Husain S, Durairaj L, et al. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet. 2002;359(9318):1648-54). • Schroeder K, Fahey T. Over-the-counter medications for acute cough in children and adults in ambulatory settings. Cochrane Database Syst Rev. 2004(4):CD001831. • Nennig ME, Shinefield HR, Edwards KM, et al. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996;275:1672-4. • Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med. 2003;138:109-18.

  42. AECB References • Anthonisen NR, Manfreda J, Warren CP et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196-204 • Snow V, Lascher S, Mottur-Pilson C; ACCP/ACP-ASIM. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2001;134:595-9. • Wilson R, Allegra L, Huchon G, et al. Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 2004;125:953-64. • Miravitlles M, Torres A. No more equivalence trials for antibiotics in exacerbations of COPD, please. Chest 2004;125:811-13.

  43. Acute Rhinosinusitis Refs • Lindbaek M, Hjortdahl P, Johnsen UL. Randomized, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ1996;313(7053):325-9. • Stalman W, van Essen GA, van der Graaf Y, de Melker RA. The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomized doxycycline trial.Br J Gen Pract 1997;47(425):794-9. • van Buchem FL, Knottnerus JA, Schrijnemaekers VJ, Peeters MF. Primary-care-based randomized placebo-controlled trial of antibiotic treatment in acute maxillary sinusitis. Lancet 1997;349(9053):683-7. • Bucher HC, Tschudi P, Young J, et al. Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice. Arch Intern Med. 2003;163:1793-8. • Merenstein D, Whittaker C, Chadwell T, et al. Are antibiotics beneficial for patients with sinusitis complaints? A randomized double-blind clinical trial. J Fam Pract. 2005;54:144-51.

  44. Acute Pharyngitis Refs • Centor RM, Witherspoon JM, Dalton HP, et al. The diagnosis of strep throat in adults in the emergency room. Med Decis Making 1981; 1:239-246. • Zwart S, Sachs APE, Ruijs GJHM, et al. Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults. BMJ 2000; 320:150-154. • DiMatteo L, Lowenstein SR, Brimhall B, et al.The relationship between the clinical features of pharyngitis and the sensitivity of a rapid antigen test: evidence of spectrum bias. Ann Emerg Med. 2001;38:648-52. • Bulloch B, Kabani A, Tenenbein M. Oral dexamethasone for the treatment of pain in children with acute pharyngitis: a randomized, double-blind, placebo-controlled trial. Ann Emerg Med. 2003;41:601-8.

More Related